Brief: Celyad Oncology Says FDA Lifts Clinical Hold Of CYAD-101-002 Phase 1b Trial

Celyad Oncology SA

01/08/2022 06:03

Aug 1 (Reuters) - Celyad Oncology SA  CYAD.BR :
    * CELYAD ONCOLOGY ANNOUNCES FDA LIFTS CLINICAL HOLD OF
CYAD-101-002 PHASE 1B TRIAL
    * U.S. FOOD AND DRUG ADMINISTRATION (FDA) HAS LIFTED
CLINICAL HOLD
ON CYAD-101-002 (KEYNOTE-B79) PHASE 1B TRIAL AFTER COMPANY MADE
CHANGES TO ELIGIBILITY CRITERIA FOR TRIAL

Source text for Eikon:  ID:nBw6dbFpDa 
Further company coverage:  CYAD.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))